| Mr Blake Denver Altom, MS, MFT INTERN | |
|
242 Rosewood Cir, Logan, UT 84321-5045 | |
| (435) 512-1304 | |
| Not Available |
| Full Name | Mr Blake Denver Altom |
|---|---|
| Gender | Male |
| Speciality | Foster Care Agency |
| Location | 242 Rosewood Cir, Logan, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255657201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 7195889-3904 (Utah) | Secondary |
| 253J00000X | Foster Care Agency | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Blake Denver Altom, MS, MFT INTERN 242 Rosewood Cir, Logan, UT 84321-5045 Ph: (435) 512-1304 | Mr Blake Denver Altom, MS, MFT INTERN 242 Rosewood Cir, Logan, UT 84321-5045 Ph: (435) 512-1304 |
News Archive
A research team led by Dr. John D. Rioux, a researcher at the Montreal Heart Institute (MHI) and professor in the faculty of medicine at the Université de Montréal, has been awarded a grant of more than $2.3 million to finance a major research project on the integrative biology of inflammatory diseases. From among the roughly 70 applications submitted, Dr. Rioux's team is one of six selected by the Canadian Institutes of Health Research to receive the Emerging Team Grant - From Genes to Proteins, Cells, Tissues and Patients.
A new preprint recently released on the bioRxiv* server describes the immunogenicity and protective potential of a novel adenovirus SARS-CoV-2 vaccine candidate against a form of the virus adapted to cause severe disease in mice. The findings show that this provides a useful mouse model for the study of new vaccines, in addition to demonstrating the protective efficacy of the current rhesus adenovirus vaccine candidate RhAd52.
With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
› Verified 2 days ago